Lantheus Appoints Vivian Yao as Chief Human Resources Officer Read more about Lantheus Appoints Vivian Yao as Chief Human Resources Officer
Lantheus Announces PYLARIFY AI™ is Now Available Read more about Lantheus Announces PYLARIFY AI™ is Now Available
Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F 18) Injection, Effective January 1, 2022 Read more about Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F 18) Injection, Effective January 1, 2022
Lantheus Holdings Announces Presentations Featuring PYLARIFY® (Piflufolastat F 18), its PSMA-Targeted Prostate Cancer Imaging Agent, at Key Scientific Meetings Read more about Lantheus Holdings Announces Presentations Featuring PYLARIFY® (Piflufolastat F 18), its PSMA-Targeted Prostate Cancer Imaging Agent, at Key Scientific Meetings
Lantheus Holdings to Present at the 4th Annual Evercore ISI HealthCONx Conference Read more about Lantheus Holdings to Present at the 4th Annual Evercore ISI HealthCONx Conference
Lantheus Holdings, Inc. Reports Third Quarter 2021 Financial Results Read more about Lantheus Holdings, Inc. Reports Third Quarter 2021 Financial Results
Lantheus Holdings to Present at Upcoming Investor Conferences Read more about Lantheus Holdings to Present at Upcoming Investor Conferences
Lantheus Holdings to Host Third Quarter 2021 Earnings Conference Call and Webcast on November 4, 2021 at 8:00 a.m. Eastern Time Read more about Lantheus Holdings to Host Third Quarter 2021 Earnings Conference Call and Webcast on November 4, 2021 at 8:00 a.m. Eastern Time
Lantheus Announces Addition of PSMA PET Imaging Agent to the National Comprehensive Cancer Network® (NCCN) Guidelines for Prostate Cancer Read more about Lantheus Announces Addition of PSMA PET Imaging Agent to the National Comprehensive Cancer Network® (NCCN) Guidelines for Prostate Cancer
Lantheus and RefleXion Announce Development and Commercialization Collaboration with the Potential to Improve Future Prostate Cancer Treatment Read more about Lantheus and RefleXion Announce Development and Commercialization Collaboration with the Potential to Improve Future Prostate Cancer Treatment
